Skip to content
Who We Serve
Private Wealth
Firefighters (FirefightersUnited™)
Police (911 Financial Services™)
Government Employees
About Us
Our Team
Our Story
Investment Strategies
Who We Serve
Private Wealth
Firefighters (FirefightersUnited™)
Police (911 Financial Services™)
Government Employees
About Us
Our Team
Our Story
Investment Strategies
Private Wealth
Firefighters (FirefightersUnited™)
Police (911 Financial Services™)
Government Employees (911 Financial Services™)
Our Story
Our Team
Investment Strategies
Contact Us
Schwab Client Login
Private Wealth
Firefighters (FirefightersUnited™)
Police (911 Financial Services™)
Government Employees (911 Financial Services™)
Our Story
Our Team
Investment Strategies
Contact Us
Schwab Client Login
Contact Us
Schwab Client Login
Recent Quotes
View Full List
My Watchlist
Adia Med Inc
Agape ATP Corporation - Common Stock
Cresco Labs Inc
Elite Pharms Inc
Everspin Technologies, Inc. - Common Stock
Grayscale Bitcoin Cash TR
Hoegh LNG Partners LP Common Units representing Limited Partner Interests
Host Hotels & Resorts
Ishares Core MSCI All Cntry Ex Can ETF
Janus Henderson Small Cap Growth Alpha ETF
Kraken Robotics Inc
Mitsui & CO Ltd ADR
Mobilicom Limited - Ordinary Shares
Oblong Inc. - Common Stock
Origin Agritech Limited - Ordinary Shares
Primoris Services Corporation - Common Stock
Principal Contrarian Value Index ETF
Pudo Inc
Semtech Corporation - Common Stock
Silicon Laboratories, Inc. - Common Stock
Simpson Manufacturing Company, Inc. Common Stock
The RMR Group Inc. - Class A Common Stock
Transcat, Inc. - Common Stock
VSE Corporation - Common Stock
Vanguard Industrials ETF
Vanguard Long-Term Treasury ETF
Vital Farms, Inc. - Common Stock
Edit Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Insulet Corporation - Common Stock
(NQ:
PODD
)
141.51
+2.74 (+1.97%)
Delayed Quote
Updated: 2:52 PM EDT, Oct 16, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Insulet Corporation - Common Stock
< Previous
1
2
...
20
21
22
23
24
25
26
27
Next >
The Daily Biotech Pulse: MacroGenics' Clinical Trial Disappointment, Sanofi to Buy Kadmon, Alector Loses 2 Key Executives, ADMA's FDA Nod
↗
September 08, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 7) Adial Pharmaceuticals, Inc...
Via
Benzinga
Insulet to Present at Upcoming Investor Conferences
August 26, 2021
From
Insulet Corporation
Via
Business Wire
Earnings Scheduled For May 6, 2021
↗
May 06, 2021
Companies Reporting Before The Bell • ViacomCBS (NASDAQ:VIAC) is projected to report quarterly earnings at $1.22 per share on revenue of $7.30 billion. • Cohen...
Via
Benzinga
Week Ahead In Biotech (May 2-8): ChemoCentryx Adcom, Ophthalmology Conference Presentations, Earnings Deluge
↗
May 01, 2021
Biopharma stocks experienced volatility in the week ended April 30, as stocks reacted to earnings, data readouts and a handful of FDA decisions. Earnings prints from big name...
Via
Benzinga
Looking into Insulet's Return on Capital Employed
↗
August 23, 2021
After pulling data from Benzinga Pro it seems like during Q2, Insulet (NASDAQ:PODD) earned $26.30 million, a 61.35% increase from the preceding quarter. Insulet also posted a...
Via
Benzinga
FDA Clears Use Of Eli Lilly's Insulin With Insulet's Infusion Pumps
↗
August 16, 2021
The
Via
Benzinga
Insulet Announces FDA Clearance of Lyumjev® Rapid-Acting Insulin for Use with Omnipod® Products in the United States
August 16, 2021
From
Insulet Corporation
Via
Business Wire
Insulet Introduces Omnipod DASH® System at Australasian Diabetes Congress
August 11, 2021
From
Insulet Corporation
Via
Business Wire
Insulet Stock Dives On Unexpected Delay For Next-Generation Insulin Pump
↗
August 06, 2021
Insulet said Thursday it expects a one-quarter delay for its next-generation insulin pump, leading PODD stock to tumble on Friday.
Via
Investor's Business Daily
Insulet Corporation (PODD) Q2 2021 Earnings Call Transcript
↗
August 06, 2021
PODD earnings call for the period ending June 30, 2021.
Via
The Motley Fool
Topics
Earnings
Insulet Reports Second Quarter 2021 Revenue Increase of 16% Year-Over-Year
August 05, 2021
From
Insulet Corporation
Via
Business Wire
3 Stocks to Buy That Should Get a Boost From Pandemic-Driven Consumer Weight Gain
↗
July 31, 2021
Athletic-apparel maker Lululemon and two diabetes specialists are poised to get a long-term tailwind from the COVID-19 pandemic.
Via
The Motley Fool
Insulet to Present at Upcoming Investor Conferences
July 26, 2021
From
Insulet Corporation
Via
Business Wire
Insulet to Announce Second Quarter 2021 Financial Results on August 5, 2021
July 01, 2021
From
Insulet Corporation
Via
Business Wire
Insulet’s Omnipod® 5 Automated Insulin Delivery System Pivotal Studies Demonstrate Improved Outcomes Across the Lifespan from Ages 2 to 70 years
June 26, 2021
From
Insulet Corporation
Via
Business Wire
Insulet to Present New Clinical Data for Preschool Children and Adults using the Omnipod® 5 System
June 24, 2021
From
Insulet Corporation
Via
Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For May 25, 2021
↗
May 25, 2021
Upgrades For Appian Corp (NASDAQ:APPN), Macquarie upgraded the previous rating of Underperform to Neutral. For the first quarter, Appian had an EPS of $0.06, compared to...
Via
Benzinga
Insulet Corp (PODD) Q1 2021 Earnings Call Transcript
↗
May 07, 2021
PODD earnings call for the period ending March 31, 2021.
Via
The Motley Fool
Topics
Earnings
Insulet Reports First Quarter 2021 Revenue Increase of 27% Year-Over-Year
May 06, 2021
From
Insulet Corporation
Via
Business Wire
Insulet to Present at BofA Securities 2021 Virtual Healthcare Conference
May 04, 2021
From
Insulet Corporation
Via
Business Wire
Insulet 2020 Sustainability Report Conveys Strategy to Deliver Growth with Purpose
May 03, 2021
From
Insulet Corporation
Via
Business Wire
The Daily Biotech Pulse: Merck's Keytruda Snags Another FDA Approval, Moderna Slips On Revenue Miss, Chemocentryx Adcom
↗
May 06, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 5) AbbVie Inc. (NYSE: ABBV)...
Via
Benzinga
The Daily Biotech Pulse: Hyperphosphatemia Drug Regulatory Review Extended, Phathom Pharma Data Readout, 2 IPOs
↗
April 30, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 29) AtriCure, Inc. (NASDAQ:...
Via
Benzinga
Insulet Announces Pricing of New Senior Secured Credit Facilities
April 29, 2021
From
Insulet Corporation
Via
Business Wire
The Daily Biotech Pulse: Clinical Setback For Adverum, Galera Posts Data Readout, Moderna To Invest In Vaccine Manufacturing, Decision Day For Ardelyx
↗
April 29, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 28) Axonics, Inc. (NASDAQ:...
Via
Benzinga
Insulet Announces Launch of Syndication of New Credit Facilities
April 19, 2021
From
Insulet Corporation
Via
Business Wire
The Daily Biotech Pulse: FDA Rejection For Protalix, Amgen Q1 Trail Estimates, Pfizer Goes Shopping
↗
April 28, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 27) Aldeyra Therapeutics, Inc...
Via
Benzinga
The Daily Biotech Pulse: Lilly, Novartis Trail Q1 Estimates, Exec Departure At Applied Genetics, Patent Award For Scholar Rock, Aldeyra Data Readout
↗
April 27, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 26) 10x Genomics, Inc. (NASDAQ...
Via
Benzinga
Topics
Intellectual Property
< Previous
1
2
...
20
21
22
23
24
25
26
27
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.